MedPath

Omeza, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:0
Completed:6

Trial Phases

3 Phases

Early Phase 1:1
Phase 1:1
Not Applicable:5

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Not Applicable
5 (71.4%)
Early Phase 1
1 (14.3%)
Phase 1
1 (14.3%)

Omeza Combination Therapy for the Management and Treatment of Chronic Cutaneous Wounds/Ulcers of Multiple Etiologies

Early Phase 1
Completed
Conditions
Non-Healing Ulcer of Skin
Non-healing Wound
First Posted Date
2023-06-27
Last Posted Date
2024-06-21
Lead Sponsor
Omeza, LLC
Target Recruit Count
111
Registration Number
NCT05921292
Locations
🇺🇸

Christus St. Vincent, Santa Fe, New Mexico, United States

Omeza Products in Combination With Standard of Care for the Treatment of Diabetic Foot Ulcers

Phase 1
Completed
Conditions
Diabetic Foot Ulcers
First Posted Date
2022-06-14
Last Posted Date
2024-06-21
Lead Sponsor
Omeza, LLC
Target Recruit Count
25
Registration Number
NCT05417425
Locations
🇺🇸

Jobst Vascular Institute, Toledo, Ohio, United States

Omeza Combination Therapy With Standard of Care to Standard of Care Alone for Chronic Venous Leg Ulcers

Not Applicable
Completed
Conditions
Venous Leg Ulcer
First Posted Date
2022-03-22
Last Posted Date
2024-06-06
Lead Sponsor
Omeza, LLC
Target Recruit Count
54
Registration Number
NCT05291169
Locations
🇺🇸

New Hope Podiatry, Los Angeles, California, United States

🇺🇸

Royal Research, Corp, Hollywood, Florida, United States

🇺🇸

Three Rivers Wound and Hyperbaric Center, North Port, Florida, United States

and more 4 locations

Skin Protectant Properties of Omeza Collagen Matrix on Damaged Skin

Not Applicable
Completed
Conditions
Erythema
Transepidermal Water Loss
First Posted Date
2020-08-13
Last Posted Date
2022-09-30
Lead Sponsor
Omeza, LLC
Target Recruit Count
22
Registration Number
NCT04512274
Locations
🇬🇧

Princeton Research Corporation, Chelmsford, Essex, United Kingdom

Irritation Potential of Omeza Collagen Matrix Using Modified HRIPT

Not Applicable
Completed
Conditions
Erythema
Sensitisation
First Posted Date
2020-08-12
Last Posted Date
2023-05-17
Lead Sponsor
Omeza, LLC
Target Recruit Count
58
Registration Number
NCT04510675
Locations
🇺🇸

PCR Corp, Saint Petersburg, Florida, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.